Atrin Pharmaceuticals

  • HOME

  • ABOUT US

    • LEADERSHIP
    • BOARD OF DIRECTORS
    • SCIENTIFIC ADVISORY BOARD

  • TARGETING DDR

  • TECHNOLOGY

  • PIPELINE

  • PUBLICATIONS

  • CONTACT US

  • More

    Use tab to navigate through the menu items.
    2019 AACR ATRN-119
    2019 AACR ATRN-119
    2019 - Yale Univ. ATRN-119 and TMZ Sensi
    2019 - Yale Univ. ATRN-119 and TMZ Sensi
    2019 Fusion ATRN-119.pdf
    2019 Fusion ATRN-119.pdf
    2018 SGO ATRN-119 Improving the efficacy
    2018 SGO ATRN-119 Improving the efficacy
    2016 Montreal DNA Repair ATRN-119
    2016 Montreal DNA Repair ATRN-119
    2016 AACR ATRN-119 Anticancer
    2016 AACR ATRN-119 Anticancer
    2016 Targeted Therapy ATRN-119
    2016 Targeted Therapy ATRN-119
    2012 JCI Oren G. & Eric B. et al.,
    2012 JCI Oren G. & Eric B. et al.,
    2010 Cancer Research Oren G. & Eric B.
    2010 Cancer Research Oren G. & Eric B.

    Copyright © 2019 Atrin Pharmaceuticals

    Tel: 267-893-6747 | E-mail: info@atrinpharma.com